RNASE1 and metabolic dysfunction-associated steatohepatitis: However, it is unknown whether eRNA plays a role in hepatic cell injury and pro-inflammatory cytokine production in NASH and whether RNase 1 administration can act as an interventional strategy to reduce NASH progression.